There were 266 press releases posted in the last 24 hours and 429,145 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Aclaris Therapeutics Submits Marketing Authorization Application in Europe for A-101 40% Topical Solution as a Novel Treatment for Seborrheic Keratosis

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image